Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apetiviton BC vs Petivit BC for Appetite Stimulation
NCT01086865Phase 3Unknown
- Sponsor
- Cifarma
- Start
- Aug 2010
- Primary completion
- Nov 2010
- Modality
- Drug Delivery Systems
01
Overview
Phase 3, randomised, double-blind trial of Apevinat BC in Loss of appetite (2 arms), sponsored by Cifarma. Primary endpoint: Effectiveness of Apetiviton BC compared to Petivit BC in appetite stimulation at 30 days. Status: unknown.
02
Drugs
Apevinat BC
03
Conditions
Loss of appetite
Beyond the preview
Go deeper on NCT01086865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01086865.